Skip to main content

Enrollment in the Health Benefits for Immigrant Adults (HBIA) program will be temporarily paused effective July 1, 2023.

Enrollment in the Health Benefits for Immigrant Seniors (HBIS) program will be temporarily paused effective Nov. 6, 2023.

Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Meeting Results June 6, 2012

Drug Name Review Type Committee Recommendation Prior Approval Status � Final Determination
Omontys New Drug Initial Review Require Prior Approval Prior Approval Required
Pulmicort Flexhaler New Drug Initial Review Require Prior Approval Prior Approval Requirement
Tradjenta New Drug Appeal Require Prior Approval Prior Approval Required
Effient New Drug Appeal Require Prior Approval Prior Approval Required
Zemplar New Drug Appeal Require Prior Approval Prior Approval Required
Daliresp New Drug Appeal Require Prior Approval Prior Approval Required
Xarelto PDL Appeal Remove Prior Approval Requirement Preferred and Require Prior Approval
Vesicare PDL Appeal Require Prior Approval Prior Approval Required